Early identification of ailments is crucial for improving patient outcomes and reducing the impact of chronic conditions. Traditionally, disease assessment has relied on clinical observations and invasive diagnostic tests. However, these strategies often fail to pinpoint diseases in their early stages, when therapy is highly effective. Recent advan